Cargando…
PLEKHA8P1 Promotes Tumor Progression and Indicates Poor Prognosis of Liver Cancer
Hepatocellular carcinoma (HCC) records the second-lowest 5-year survival rate despite the avalanche of research into diagnosis and therapy. One of the major obstacles in treatment is chemoresistance to drugs such as 5-fluorouracil (5-FU), making identification and elucidation of chemoresistance regu...
Autores principales: | Lee, Jiyeon, Hwang, Ji-Hyun, Chun, Harim, Woo, Wonjin, Oh, Sekyung, Choi, Jungmin, Kim, Lark Kyun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8304620/ https://www.ncbi.nlm.nih.gov/pubmed/34299245 http://dx.doi.org/10.3390/ijms22147614 |
Ejemplares similares
-
WW, PH and C-Terminal Domains Cooperate to Direct the Subcellular Localizations of PLEKHA5, PLEKHA6 and PLEKHA7
por: Sluysmans, Sophie, et al.
Publicado: (2021) -
PLEKHA5, PLEKHA6, and PLEKHA7 bind to PDZD11 to target the Menkes ATPase ATP7A to the cell periphery and regulate copper homeostasis
por: Sluysmans, Sophie, et al.
Publicado: (2021) -
PLEKHA7 modulates epithelial tight junction barrier function
por: Paschoud, Serge, et al.
Publicado: (2014) -
19. PLEKHA5 REGULATES TUMOR GROWTH IN METASTATIC MELANOMA
por: Oria, Victor, et al.
Publicado: (2020) -
Origin and Evolution of the Multifaceted Adherens Junction Component Plekha7
por: Kourtidis, Antonis, et al.
Publicado: (2022)